Dorsavi Ltd (ASX: DVL) - Share Price
- Current share price for DVL : $0.027
DorsaVi Ltd (DVL) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is an ASX listed company developing motion analysis device technologies for clinical use, elite sports, and occupational health and safety. The entity states that its wearable sensor technology enables detailed aspects of human movement and position to be captured, quantified, and assessed outside a biomechanics laboratory in real time and in practical environments for periods of up to 24 hours.
DVL General Information +
| ASX Code | DVL |
| Website | http://www.dorsavi.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 33 |
| DVL Share Price | $0.027 |
| Day High | $0.027 |
| Day Low | $0.026 |
| Last Close | $0.027 |
| DVL Share Price Movement | - ( No change ) |
Prices as at 16:40, 25 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Dorsavi Ltd (DVL) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Dorsavi Ltd (DVL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Dorsavi Ltd (DVL) price-sensitive announcements
DVL - dorsaVi Completes CMOS Fabrication for RRAM Validation Chip
dorsaVi Limited announced the successful completion of the front-end-of-line and middle-of
Dorsavi Ltd (DVL)
24 Aug 2026 | 8:48 AM
24 Aug 2026 | 8:48 AM
DVL - dorsaVi Commences Fabrication of First RRAM-CMOS Chip
dorsaVi Limited has commenced the fabrication of its first RRAM-CMOS validation chip, a si
Dorsavi Ltd (DVL)
12 Aug 2026 | 9:41 AM
12 Aug 2026 | 9:41 AM
DVL - Quarterly Activities/Appendix 4C Cash Flow Report
Dorsavi Ltd's quarterly activities report details a significant focus on operational activ
Dorsavi Ltd (DVL)
30 Jul 2026 | 9:13 AM
30 Jul 2026 | 9:13 AM
DVL - dorsaVi v6.5 Sensor Advances Physical AI Strategy
dorsaVi Ltd, an ASX-listed company, announced the launch of its Sensor v6.5, a wearable de
Dorsavi Ltd (DVL)
28 Jul 2026 | 8:44 AM
28 Jul 2026 | 8:44 AM
Dorsavi Ltd (DVL) Recent ASX Announcements
DVL Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$8.52 | -$0.80 | 245.50% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$1.52 | -$0.20 | -4.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$1.25 | -$0.20 | -41.00% | 0.00 | 0.00 | 0.00% | 0.0% |
DVL Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| Cochlear Limited (COH) | $9,339M | -0.3136 | 0.2540 | 0.0785 | 34.7657 | 27.7238 | 25.7061 | 2.42% | 2.51% | 2.73% |
| Dorsavi Ltd (DVL) | $33M | 2.4545 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $21,242M | 0.1388 | 0.1545 | 0.1574 | 54.6046 | 47.2954 | 40.8623 | 1.20% | 1.31% | 1.45% |
| Imricor Medical Systems Inc (IMR) | $617M | -0.4254 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| ResMed Inc. (RMD) | $18,421M | 9.5922 | 0.0986 | 0.0915 | 20.5831 | 18.7363 | 17.1658 | 1.13% | 1.23% | 1.32% |
DVL Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 7.71 | 0.00 |
| Market | 0.33 | 13.80 | 1.17 | 0.79 |
| Sector | 0.62 | 20.80 | 1.80 | 2.50 |
DVL Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Leigh Daniel Travers | Non-Executive Director | 4 Dec 2024 |
| Mr Vineet Agarwal | Non-Executive Director | 16 Sep 2024 |
| Mr Gernot Kurt Abl | Non-Executive Director, Non-Executive Chairman | 13 Mar 2024 |
Dorsavi Ltd (DVL) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 15 Nov 2024 | WINLO, Michael | Issued | Direct Shares | 2,797,394 | $0.012 | $32,729.510 |
| 15 Nov 2024 | RONCHI, Andrew | Issued | Indirect Shares | 3,636,363 | $0.011 | $39,999.993 |
| 15 Nov 2024 | ABL, Gernot | Issued | Indirect Shares | 1,619,821 | $0.012 | $18,951.906 |
See all changes in directors' interest & trades for Dorsavi Ltd (DVL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
DVL Management
| Name | Position |
|---|---|
| Mathew Regan | Chief Executive Officer |
| Justin Mouchacca | Company Secretary |
DVL Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Dorsavi Ltd (DVL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 91,075,928 (8.09%) | Ifrah Nishat |
| 58,994,271 (5.24%) | Chunyan Niu |
DVL Calendar of Events
| Date | Event |
|---|---|
| 30 August 2027 | Report (Annual) |
| 30 August 2027 | Report (Prelim) |
| 25 February 2027 | Report (Interim) |
| 28 September 2026 | Report (Annual) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
